Pub. Date : 2015 Jan
PMID : 25373357
5 Functional Relationships(s)Download |
Sentence | Compound Name | Protein Name | Organism |
1 | Relationships between the antidotal efficacy and structure, PK/PD parameters and bio-relevant molecular descriptors of AChE reactivating oximes: inclusion and integration to biopharmaceutical classification systems. | Oximes | acetylcholinesterase (Cartwright blood group) | Homo sapiens |
2 | INTRODUCTION: The therapeutic outcome of oximes used as reactivators of phosphorylated human acetylcholinesterase (AChE) is influenced, among other factors, by their biological distribution, their in vivo ability to achieve the nucleophilic attack and their affinity for the anionic center of the intact/inhibited AChE. | Oximes | acetylcholinesterase (Cartwright blood group) | Homo sapiens |
3 | INTRODUCTION: The therapeutic outcome of oximes used as reactivators of phosphorylated human acetylcholinesterase (AChE) is influenced, among other factors, by their biological distribution, their in vivo ability to achieve the nucleophilic attack and their affinity for the anionic center of the intact/inhibited AChE. | Oximes | acetylcholinesterase (Cartwright blood group) | Homo sapiens |
4 | INTRODUCTION: The therapeutic outcome of oximes used as reactivators of phosphorylated human acetylcholinesterase (AChE) is influenced, among other factors, by their biological distribution, their in vivo ability to achieve the nucleophilic attack and their affinity for the anionic center of the intact/inhibited AChE. | Oximes | acetylcholinesterase (Cartwright blood group) | Homo sapiens |
5 | EXPERT OPINION: The structural differences of the organophosphorus compounds (OP) and the available oximes reactivators of OP-inhibited AChE generate distinct toxicokinetic or PK profiles. | Oximes | acetylcholinesterase (Cartwright blood group) | Homo sapiens |